Compare CENX & MMSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CENX | MMSI |
|---|---|---|
| Founded | 1995 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Aluminum | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.9B | 4.0B |
| IPO Year | 2004 | 1996 |
| Metric | CENX | MMSI |
|---|---|---|
| Price | $66.98 | $68.05 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 8 |
| Target Price | $63.00 | ★ $100.38 |
| AVG Volume (30 Days) | ★ 2.3M | 709.8K |
| Earning Date | 05-06-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 4.93 |
| EPS | 0.42 | ★ 2.13 |
| Revenue | ★ $1,893,200,000.00 | $1,515,906,000.00 |
| Revenue This Year | $18.24 | $8.78 |
| Revenue Next Year | $10.47 | $5.76 |
| P/E Ratio | $157.88 | ★ $32.19 |
| Revenue Growth | N/A | ★ 11.75 |
| 52 Week Low | $14.77 | $66.34 |
| 52 Week High | $68.69 | $99.26 |
| Indicator | CENX | MMSI |
|---|---|---|
| Relative Strength Index (RSI) | 70.49 | 39.87 |
| Support Level | $45.49 | $66.76 |
| Resistance Level | N/A | $71.57 |
| Average True Range (ATR) | 3.80 | 1.80 |
| MACD | 1.38 | 0.46 |
| Stochastic Oscillator | 92.87 | 34.62 |
Century Aluminum Co produces primary aluminum standard grade and value-added products. The firm operates smelter facilities in the United States and Iceland. The majority of revenue is generated from Glencore, which agreed to purchase nearly all of Century Aluminum's North American production. The company produces high purity aluminum, standard-grade aluminum sow and tee bars, and value-added billet and foundry products. The company also owns a carbon anode production facility in the Netherlands.
Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. The majority of the revenue is earned from the Cardiovascular segment which consists of cardiology and radiology medical device products that assist in diagnosing and treating coronary artery disease, peripheral vascular disease, and other non-vascular diseases and includes embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, and interventional oncology and spine devices.